The Use of Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with History of Intra-Cranial Hemorrhage.
CONCLUSIONS: -Warfarin use may be beneficial for AF patients with prior ICH having a CHA2DS2-VASc score ≥6. Whether the use of non-vitamin K antagonist oral anticoagulants (NOACs) could lower the threshold for treatment deserves further study.
PMID: 26969761 [PubMed - as supplied by publisher]
Source: Circulation - Category: Cardiology Authors: Chao TF, Liu CJ, Liao JN, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chen TJ, Lip GY, Chen SA Tags: Circulation Source Type: research
More News: Atrial Fibrillation | Cardiology | Coumadin | Databases & Libraries | Health | Health Insurance | Hemorrhagic Stroke | Insurance | Ischemic Stroke | Stroke | Study | Vitamins | Warfarin